About Us

Advancing Precision Genetic Therapies That Restore and Preserve Hearing

Listening is in our DNA.

Ακούω in Greek translates to Listen in English. At Akouos (ah KOO ohs), we strive to be a team that listens to one another, to healthcare providers, and to the deaf and hard of hearing (D/HH) community. Our partnerships and collaborations are focused on common goals and predicated on respect, trust, and transparency.

Common Goal Partnerships

In partnering with the D/HH community, we will use the principles outlined here as our guide.

Hearing loss is one of the greatest challenges in medicine today, and with no FDA-approved pharmacologic therapies available, an area of severe unmet need.

Manny Simons, PH.Dfounder and CEO of Akouos

We Are Akouos

  • Filter By:

  • Eva Andres-Mateos

    TRANSLATIONAL MEDICINE

  • Yukako Asai

    ANATOMY & PHYSIOLOGY

  • Priya Bansode

    AAV MOLECULAR BIOLOGY

  • Jean Bennett

    SCIENTIFIC ADVISORY BOARD

  • Steve Burke

    HUMAN RESOURCES

  • Robyn Chiang

    AAV MOLECULAR BIOLOGY

  • John Connelly

    PORTFOLIO STRATEGY & PRODUCT DEVELOPMENT

  • Yuanzhao Darcy

    ANATOMY & PHYSIOLOGY

  • Samantha Davis

    ANATOMY & PHYSIOLOGY

  • Shimon Francis

    ANATOMY & PHYSIOLOGY

  • Yuan Gao

    ANATOMY & PHYSIOLOGY

  • Alan Gilstrap

    ADVOCACY & ENGAGEMENT

  • Katherine Gribble

    AAV MOLECULAR BIOLOGY

  • Lakeija Hall

    OFFICE MANAGEMENT

  • Brittany Hasili

    FINANCE

  • Eric Horowitz

    PROCESS & ANALYTICAL DEVELOPMENT

  • Gregg Hughes

    PROCESS & ANALYTICAL DEVELOPMENT

  • Aninda Katragadda

    FINANCE

  • Judith Kelly

    EXECUTIVE ADMINISTRATION

  • Mary LeBlanc

    FINANCE

  • Kathy Lennon

    CLINICAL

  • Danielle Lenz

    AAV MOLECULAR BIOLOGY

  • Rodrigo Lopez

    PROCESS & ANALYTICAL DEVELOPMENT

  • Alex Martinez

    ANATOMY & PHYSIOLOGY

  • Ed Mathers

    BOARD OF DIRECTORS

  • Michael McKenna

    FOUNDER & CHIEF MEDICAL OFFICER

  • Robert Ng

    AAV MOLECULAR BIOLOGY

  • Dan Paquette

    OPERATIONS

  • Kush Parmar

    BOARD OF DIRECTORS

  • Jean Phillips

    CLINICAL

  • Enping Qu

    AAV MOLECULAR BIOLOGY

  • Greg Robinson

    CHIEF SCIENTIFIC OFFICER

  • Jennifer Santos

    ANATOMY & PHYSIOLOGY

  • Pascal Schamber

    ANATOMY & PHYSIOLOGY

  • William Sewell

    FOUNDER

  • Emmanuel Simons

    FOUNDER & CHIEF EXECUTIVE OFFICER

  • Chris Smith

    BOARD OF DIRECTORS

  • Richard Smith

    FOUNDER

  • Jenna Soper

    PROGRAM MANAGEMENT

  • Aaron Tward

    SCIENTIFIC ADVISORY BOARD

  • Arthur Tzianabos

    BOARD OF DIRECTORS

  • Michelle Valero

    ANATOMY & PHYSIOLOGY

  • Luk Vandenberghe

    FOUNDER

  • Suzanne Walker

    EXECUTIVE ADMINISTRATION

  • Jennifer Wellman

    REGULATORY & QUALITY

  • Brianna Whelan

    OPERATIONS

Our Partners

Join us in the pursuit of healthy hearing for all.

What’s at our core

We Work to Change Lives

Akouos listens: to each other, to the individuals and families we work to serve, to our collective conscience.
Akouos engages: Honestly, transparently, respectfully.
Akouos leads: Authentically, boldly, bravely, with purpose and passion.
Akouos creates: High standards, opportunities to excel, better medicines.
Akouos trusts: Ourselves, each other, our science.

Join us in the pursuit of healthy hearing for all.

Akouos is building the leading gene therapy company focused on hearing disorders. Our objectives are to restore the inner ear’s ability to produce functional proteins required for hearing, rejuvenate structures of the hearing circuit critical for high-fidelity signal transduction and inner ear homeostasis, and reinforce healthy hearing with local, enduring protein production to protect against drug-, noise-, and age- associated ototoxicity.